Websites Hosted in ns3.bms.com Nameserver

- bms.com

Bristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases.

42,954 $ 416,160.00

- medarex.com

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

Not Applicable $ 8.95

- zymogenetics.com

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

Not Applicable $ 8.95

- bmsi.co.in

Learn more about Bristol-Myers Squibb and our mission to discover, develop and deliver innovative medicines to patients with serious diseases.

Not Applicable $ 8.95

- abatacept.biz

Take an assessment; learn about ORENCIA On Call; get help with insurance questions, co-pay assistance, financial support; watch the ORENCIA TV commercial; review the Important Safety Information and Full Prescribing Information

Not Applicable $ 8.95

- nivolumabdrugresearchstudies.com

Overview of an investigational nivolumab treatment being studied for several types of cancer, including lung cancer, renal cell carcinoma, and melanoma.

Not Applicable $ 8.95

- bmsfrance.fr

Découvrez Bristol-Myers Squibb et sa mission visant à découvrir, développer et fournir des médicaments innovants qui aident les patients à vaincre des maladies graves.

Not Applicable $ 8.95

- orencia.com

ORENCIA® (abatacept) is a prescription medication for moderate to severe Adult Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, and Adult Psoriatic Arthritis. Please see Indication and Important Safety Information.

2,198,441 $ 480.00

- bmsireland.ie

Learn more about Bristol-Myers Squibb and our mission to discover, develop and deliver innovative medicines to patients with serious diseases.

Not Applicable $ 8.95

- nulojixhcp.bmscustomerconnect.com

NULOJIX® (belatacept) official HCP Web site; View Important Safety Information, including Boxed WARNINGS and Full Prescribing Information.

668,938 $ 1,920.00

- opdivoguidepatients-egsa.com

Immune-related adverse reactions (irARs) that have been reported in association with nivolumab use both in monotherapy and in combination therapy with ipilimumab

Not Applicable $ 8.95

- opdivoguide-egsa.com

Immune-related adverse reactions (irARs) that have been reported in association with nivolumab use both in monotherapy and in combination therapy with ipilimumab

Not Applicable $ 8.95

- treatadvancedrcc.com

OPDIVO + YERVOY combination for certain people with kidney cancer that has spread. See Boxed WARNING for YERVOY, Important Safety Information and Indication.

Not Applicable $ 8.95